RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cell Kinetics Stock

Cell Kinetics EBIT 2025

Cell Kinetics EBIT

-2.4 M USD

Ticker

CKNTF

ISIN

IL0011098758

WKN

A0MV4W

In 2025, Cell Kinetics's EBIT was -2.4 M USD, a 15.38% increase from the -2.08 M USD EBIT recorded in the previous year.

The Cell Kinetics EBIT history

YEAREBIT (undefined USD)
2008-
2007-
2006-
2005-

Cell Kinetics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cell Kinetics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cell Kinetics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cell Kinetics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cell Kinetics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cell Kinetics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cell Kinetics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cell Kinetics’s growth potential.

Cell Kinetics Revenue, EBIT and net profit per share

DateCell Kinetics RevenueCell Kinetics EBITCell Kinetics Net Income
200820,000 undefined-2.4 M undefined-2.38 M undefined
20070 undefined-2.08 M undefined-2.1 M undefined
20060 undefined-1.78 M undefined-1.81 M undefined
20050 undefined-1.75 M undefined-1.77 M undefined

Cell Kinetics stock margins

The Cell Kinetics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cell Kinetics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cell Kinetics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cell Kinetics's sales revenue. A higher gross margin percentage indicates that the Cell Kinetics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cell Kinetics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cell Kinetics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cell Kinetics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cell Kinetics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cell Kinetics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cell Kinetics Margin History

Cell Kinetics Gross marginCell Kinetics Profit marginCell Kinetics EBIT marginCell Kinetics Profit margin
200850 %-12,000 %-11,900 %
200750 %0 %0 %
200650 %0 %0 %
200550 %0 %0 %

Cell Kinetics Aktienanalyse

What does Cell Kinetics do?

Cell Kinetics Ltd is a company specializing in the research and production of cell therapy products. The company was founded in 2020 and is based in London, United Kingdom. Cell Kinetics Ltd has a visionary mission that inspires the company to discover and develop groundbreaking solutions to improve people's health and well-being. The company aims to research, develop, and deliver therapies for serious diseases such as cancer and neurodegenerative disorders. The business model of Cell Kinetics Ltd is based on comprehensive research of new cell therapies and collaboration with academic partners to validate the clinical benefits of these therapies. The company has established partnerships with leading academic institutions and medical centers in Europe and the USA. Cell Kinetics Ltd works in various areas to achieve the goal of discovering and developing new therapies for serious diseases. An important focus of the company is the development of cell culture methods for the production and maintenance of therapeutic cells in large quantities. The company has extensive experience in developing artificial platforms for cell cultivation, including bioreactor-based cultivation, single-cell-sensitive cultivation, and the use of chemicals for cell cultivation. Another focus of Cell Kinetics Ltd is the development of carcinoma therapies. The company has developed a special technology for the production of T-cells that can be used to kill cancer cells. These T-cells are obtained from blood samples of cancer patients and cultivated in vitro. The company has also developed a technology that allows these T-cells to be modified to fight deadly diseases such as leukemia and lymphoma. Another focus of Cell Kinetics Ltd is the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company is developing special technologies to differentiate neural stem cells that can serve as a therapeutic tool for the treatment of these diseases. These neural stem cells can be used to repair damaged nerve cells. Cell Kinetics Ltd is proud to offer a range of products that can contribute to improving the health and well-being of patients. The company offers therapy products for cancer treatment, neurodegenerative diseases, and cardiovascular diseases, among others. In addition, the company also provides a wide range of services, including the development and production of cell therapy products, as well as artificial platforms for cell cultivation. Overall, Cell Kinetics Ltd has become a major player in the field of cell therapy and the development of therapies for serious diseases. The company is committed to continuing to develop groundbreaking discoveries and technologies to improve the lives of millions of people around the world. Cell Kinetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Cell Kinetics's EBIT

Cell Kinetics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cell Kinetics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cell Kinetics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cell Kinetics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cell Kinetics stock

How much did Cell Kinetics achieve in EBIT for the current year?

In the current year, Cell Kinetics has achieved an EBIT of -2.4 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Cell Kinetics.

How has the EBIT of Cell Kinetics developed in recent years?

The EBIT of Cell Kinetics has increased by 15.385% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Cell Kinetics?

The EBIT of Cell Kinetics is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Cell Kinetics pay?

Over the past 12 months, Cell Kinetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cell Kinetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cell Kinetics?

The current dividend yield of Cell Kinetics is .

When does Cell Kinetics pay dividends?

Cell Kinetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cell Kinetics?

Cell Kinetics paid dividends every year for the past 0 years.

What is the dividend of Cell Kinetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cell Kinetics located?

Cell Kinetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cell Kinetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cell Kinetics from 1/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/4/2025.

When did Cell Kinetics pay the last dividend?

The last dividend was paid out on 1/4/2025.

What was the dividend of Cell Kinetics in the year 2024?

In the year 2024, Cell Kinetics distributed 0 USD as dividends.

In which currency does Cell Kinetics pay out the dividend?

The dividends of Cell Kinetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cell Kinetics

Our stock analysis for Cell Kinetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cell Kinetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.